Biotalk

During this episode of Biotalk, Geoff Meyerson, CEO of Locust Walk, unpacks our 2024 Q1 Report: Global Trends in Biopharma Transactions Report. Each quarter, Locust Walk’s deal team compiles key statistics and trends showcasing the current state of global private and public capital markets, strategic partnerships, and M&A in the biopharma sector.   In this episode, Geoff […]

On this episode of Biotalk, Locust Walk’s Geoff Meyerson welcomes Kendalle Burlin O’Connell, Esq., CEO and President of MassBio, the nation’s pioneering biotechnology trade association, which plays a pivotal role in representing and supporting the vibrant Massachusetts life sciences industry. In this insightful conversation, Kendalle discusses her journey from law to leading MassBio in 2008, […]

During this episode of Biotalk, Geoff Meyerson, CEO of Locust Walk, unpacks our 2023 Year-In-Review Report: Global Trends in Biopharma Transactions Report. Each quarter, Locust Walk’s deal team compiles key statistics and trends showcasing the current state of global private and public capital markets, strategic partnerships, and M&A in the biopharma sector. In this episode, Geoff […]

On this episode of Biotalk, Locust Walk‘s Geoff Meyerson welcomes Soufiane Aboulhouda, Co-Founder and Chairman of the Board of Nucleate, a global non-profit dedicated to empowering future biotech leaders through education and fostering innovation in life sciences companies. The discussion explores Soufiane’s journey into early-stage biotech and delves into the founding story of Nucleate, highlighting the […]

On this episode of Biotalk, Locust Walk‘s Daniel Brog welcomes with Shehnaaz Suliman, M.D., CEO of ReCode Therapeutics, a clinical-stage genetic medicines company using its selective organ targeting lipid nanoparticle platform to power the next wave of mRNA and gene correction therapeutics. With over 25 years of experience, Shehnaaz brings a multifaceted perspective to the discussion. She […]

On this episode of Biotalk, Locust Walk‘s Geoff Meyerson welcomes Errik Anderson, CEO and Founder of Alloy Therapeutics, to the podcast. Alloy is a trailblazing drug-discovery company, bringing collaborative platforms and services to the biotech world, making cutting-edge biologics accessible to everyone, from academia and small biotechs to major pharmaceutical companies. Errik, with a unique blend of entrepreneurship, […]

During this episode of Biotalk, Geoff Meyerson, CEO of Locust Walk, delves into our 2023 Q3 Report: Global Trends in Biopharma Transactions Report. Each quarter, Locust Walk’s deal team compiles key statistics and trends showcasing the current state of global private and public capital markets, strategic partnerships, and M&A in the biopharma sector.  In this […]

On this episode of Biotalk, Locust Walk‘s Geoff Meyerson welcomes Onaiza Cadoret-Manier, Executive Vice President, Chief Global Product Strategy & Operations Officer at Ionis Pharmaceuticals to the podcast. With 30 years of experience in life sciences, Onaiza is a member of Ionis’ executive leadership team, overseeing the company’s portfolio planning, global product strategy, medical affairs, […]

During this episode of Biotalk, Geoff Meyerson, CEO of Locust Walk, unpacks our 2023 Q2 Report: Global Trends in Biopharma Transactions Report. Each quarter, Locust Walk’s deal team compiles key statistics and trends showcasing what is happening in the global private and public capital markets, strategic partnering, and M&A. To download this report, please go to locustwalk.com and […]

This episode of Biotalk is focused on Locust Walk’s 2023 First Quarter Market Conditions Report, in which we apply the latest data to analyze current activities in the life sciences deal landscape. Each quarter, Locust Walk’s deal team compiles key statistics and trends showcasing what is happening in the global private and public capital markets […]

On this episode of Biotalk, Locust Walk welcomes Andrew Allen, M.D., Ph.D., Co-Founder, President, CEO, and board member of Gritstone Bio to the podcast. Prior to Gritstone, Dr. Allen co-founded Clovis Oncology and served as CMO. He was CMO at Pharmion Corporation and also served in clinical development leadership roles at Chiron Corporation and Abbott […]

Our first Biotalk podcast is focused on Locust Walk’s 2022 year-in-review market conditions, which was released the first day of JPMorgan and rapidly accumulated over 500 downloads. Each quarter, Locust Walk’s deal team compiles key statistics and trends showcasing what is happening in the global private and public capital markets and strategic partnering and M&A. […]

https://www.locustwalk.com/wp-content/uploads/2015/10/2_24_15_BusinessofHealthcare_5.m4a   // // // //Use outerHeight() instead of height() if have padding var aboveHeight = $j('#header-bg-container').outerHeight(); //when scroll $j(window).scroll(function () { //if scrolled down more than the header's height if ($j(window).scrollTop() > aboveHeight) { // if yes, add "fixed" class to the // add padding top to the #content // (value is same as the height of the nav) $j('.sticky').addClass('fixed-menu').css('top', '0'); //.next().css('padding-top','88px'); // Add Drop Shadow to Menu // $j('#nav-bg-container').addClass('menu-shadow'); } else { // when scroll up or less than aboveHeight, // remove the "fixed" class, and the padding-top $j('.sticky').removeClass('fixed-menu').next().css('padding-top', '0'); //Remove the drop shadow $j('#nav-bg-container').removeClass('menu-shadow'); } }); }); // ]]>// 0) { ga('create', _gac, 'auto'); ga('send', 'pageview'); } // ]]> And click here for Wharton's Business Radio on Sirius XM to hear experts opine on the revolutionary changes such as the Affordable Care Act and other legislative and regulatory developments occurring in the healthcare industry.